The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Prevalence of Antibodies in Human Sera against JC Virus, an Isolate from a Case of Progressive Multifocal Leukoencephalopathy
Abstract
Sera from 406 people of various ages throughout the state of Wisconsin were assayed for antibodies against IC virus, a new human papova-like virus isolated from a patient with progressive multifocal leukoencephalopathy. The hemagglutination-inhibition (HAl) test was used after it was determined that a linear relationship existed between the titers of HAI and neutralizing antibodies in human sera. About 69% (191/277) of the adults tested had significant levels of antibodies against IC virus in their serum. The highest rate of conversion to seropositivity occurred during the first 14 years of life. No sex difference in the incidence of antibodies against IC virus was found.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
Amino acid metabolism in Mammalian cell cultures
Eagle, H. (1959) · Science · doi:10.1126/science.130.3373.432 · Cited by 4,011 · cited 1×
“(Eagle [3]) containing nonessential amino acids, L-glutamine, and antibiotics (MEM).”
CULTIVATION OF PAPOVA-LIKE VIRUS FROM HUMAN BRAIN WITH PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY
Padgett, B., Zurhein, G., Walker, D., Eckroade, R., & Dessel, B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91777-6 · Cited by 1,624
Self-citationNEW HUMAN PAPOVAVIRUS (B.K.) ISOLATED FROM URINE AFTER RENAL TRANSPLANTATION
Gardner, S., Field, A., Coleman, D., & Hulme, B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91776-4 · Cited by 1,497
Isolation of Virus Related to SV40 from Patients with Progressive Multifocal Leukoencephalopathy
Weiner, L. P., Herndon, R. M., Narayan, O., Johnson, R. T., Shah, K. V., Rubinstein, L. J., Preziosi, T. J., & Conley, F. K. (1972) · New England Journal of Medicine · doi:10.1056/nejm197202242860801 · Cited by 287
A SURVEY OF PRIMATE SERA FOR ANTIBODIES TO VIRUSES OF HUMAN AND SIMIAN ORIGIN1
KALTER, S. S., Ratner, J. J., Kalter, G. V., Rodriguez, A. R., & Kim, C. S. (1967) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120765 · Cited by 33
Cited by
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
Van Assche, G., Van Ranst, M., Sciot, R., Dubois, B., Vermeire, S., Noman, M., Verbeeck, J., Geboes, K., Robberecht, W., & Rutgeerts, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051586 · Cited by 1,060
Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
Langer-Gould, A., Atlas, S. W., Green, A. J., Bollen, A. W., & Pelletier, D. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051847 · Cited by 1,034
Tan, C. S., & Koralnik, I. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70040-5 · Cited by 776
Metadata
- Authors
- Padgett, B. L., & Walker, D. L.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1973-04-01
- Volume
- 127
- Issue
- 4
- Pages
- 467-470
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2056695829
- Cited by
- 479
- References
- 6
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.